Cite
CML-363 Recent Perspective of Next-Generation Sequencing (NGS) in Mechanisms of Resistance in Patients With Chronic Myeloid Leukemia
MLA
Daria Kustova, et al. “CML-363 Recent Perspective of Next-Generation Sequencing (NGS) in Mechanisms of Resistance in Patients With Chronic Myeloid Leukemia.” Clinical Lymphoma Myeloma and Leukemia, vol. 22, Oct. 2022, p. S294. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........3a4b861d4e23ed51cad49a6c5fd040a8&authtype=sso&custid=ns315887.
APA
Daria Kustova, Ekaterina Motyko, Anna Kirienko, Marina Bakay, Elizaveta Efremova, Natalya Semenova, Natella Enukashvily, Sergei Voloshin, Vasily Shuvaev, Sergei Sidorkevich, & Irina Martynkevich. (2022). CML-363 Recent Perspective of Next-Generation Sequencing (NGS) in Mechanisms of Resistance in Patients With Chronic Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia, 22, S294.
Chicago
Daria Kustova, Ekaterina Motyko, Anna Kirienko, Marina Bakay, Elizaveta Efremova, Natalya Semenova, Natella Enukashvily, et al. 2022. “CML-363 Recent Perspective of Next-Generation Sequencing (NGS) in Mechanisms of Resistance in Patients With Chronic Myeloid Leukemia.” Clinical Lymphoma Myeloma and Leukemia 22 (October): S294. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........3a4b861d4e23ed51cad49a6c5fd040a8&authtype=sso&custid=ns315887.